Emcure Pharmaceuticals Approves Subsidiary Amalgamation Scheme
Emcure Pharmaceuticals’ board approves a draft scheme to amalgamate its wholly owned subsidiaries Zuventus Healthcare and Emcutix Biopharmaceuticals with the parent company.
Draft Composite Scheme | 14/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy